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Mechanical complications after myocardial infarction reliably
predicted using C-reactive protein levels and lymphocytopenia
Abstract
We assessed the accuracy of C-reactive protein (CRP) levels and lymphocyte counts to predict a
mechanical complication (MC) after myocardial infarction (MI). Within 10 years, we identified 36
patients with 39 echocardiographically confirmed MC within 30 days of MI: ventricular septal defect
(17 cases), papillary muscle rupture (10 cases), and left ventricular free wall rupture (12 cases). They
were compared to 41 controls with an uncomplicated hospital course after MI. Peak CRP levels and
minimum relative lymphocyte counts obtained within 96 h of the acute MI (AMI) and before diagnosis
of the complication were compared with clinical parameters. Prior to the MC, peak CRP levels were
significantly higher (p < 0.001) and relative lymphocyte counts lower (p < 0.001) than in controls while
creatine kinase levels did not differ (p = nonsignificant). Using multivariate logistic regression, the
following score was identified to have excellent prognostic significance for MC: CRP (mg/l) - 10 x Lyc
(%). The area under the receiver-operating characteristic curve was 0.90 +/- 0.05 (p < 0.001). Combined
use of CRP levels and relative lymphocyte counts may be helpful in accurately predicting an MC after
AMI and should therefore be routinely assessed.
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Abstract
We assessed the accuracy of C-reactive protein (CRP)
levels and lymphocyte counts to predict a mechanical
complication (MC) after myocardial infarction (MI). With-
in 10 years, we identified 36 patients with 39 echocardio-
graphically confirmed MC within 30 days of MI: ventricu-
lar septal defect (17 cases), papillary muscle rupture (10
cases), and left ventricular free wall rupture (12 cases).
They were compared to 41 controls with an uncompli-
cated hospital course after MI. Peak CRP levels and mini-
mum relative lymphocyte counts obtained within 96 h of
the acute MI (AMI) and before diagnosis of the complica-
tion were compared with clinical parameters. Prior to the
MC, peak CRP levels were significantly higher (p ! 0.001)
and relative lymphocyte counts lower (p ! 0.001) than in
controls while creatine kinase levels did not differ (p =
nonsignificant). Using multivariate logistic regression,
the following score was identified to have excellent prog-
nostic significance for MC: CRP (mg/l) – 10 ! Lyc (%).
The area under the receiver-operating characteristic
curve was 0.90 B 0.05 (p ! 0.001). Combined use of CRP
levels and relative lymphocyte counts may be helpful in
accurately predicting an MC after AMI and should there-
fore be routinely assessed.
Copyright © 2003 S. Karger AG, Basel
Introduction
Mechanical complications (MC) after acute myocar-
dial infarction (AMI) include papillary muscle rupture
(PMR) with severe mitral regurgitation, ventricular septal
rupture with a ventricular septal defect (VSD) and free-
wall rupture (FWR). Although infrequently occurring (af-
fecting 2–3% of patients with AMI [1]), the poor progno-
sis of an MC if left uncorrected demands early diagnosis
based on a high degree of suspicion. Previous reports have
focused mainly on clinical and pathological risk factors
for MC [1–10]. Known risk factors include advanced age,
female gender, a first, anterior or transmural myocardial
infarction (MI), and no history of previous smoking [3, 6,
7, 11]. Furthermore, ST-segment elevation in lead aVL on
the admission ECG, abrupt hypotension or bradycardia
have been described to be related to MC [12]. Still, the
predictive value of these features to identify patients like-
ly to sustain an MC is limited.
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The prognostic significance of laboratory tests such as
raised serum levels of the acute-phase reactant C-reactive
protein (CRP) after an AMI has rarely been examined [8,
11]. A raised CRP level has been described as a predictor
of FWR [8, 11]. However, the prognostic relevance of ele-
vated CRP levels for other MC has never been explored.
Another potentially useful marker of an MC after AMI
may be relative lymphocytopenia (defined as a percentage
of lymphocytes !20% of all white blood cells, WBC [13]),
reflecting a stressful state with increased cortisol release
correlating with infarct size [10, 14].
We tested the hypothesis that combined use of both
markers, elevated CRP and relative lymphocytopenia,
enables an accurate prediction of MC after AMI. For this
purpose, we retrospectively compared clinical and labora-
tory data of patients with an echocardiographically prov-
en MC after AMI to patients with an uncomplicated hos-
pital course (controls).
Patients and Methods
Patients
We reviewed the charts of all 69 consecutive patients admitted to
our department between January 1990 and October 2000 suffering
an MC within 30 days of an AMI. MC were defined as echocardio-
graphically confirmed VSD, PMR or FWR located within the
infarcted region. We included only those 36 patients with 39 MC who
had full documentation of CRP levels and relative lymphocyte
counts within the first 96 h after AMI. Baseline characteristics of the
patients with incomplete data did not differ from those included in
the study (data not shown).
The control group comprised patients admitted during 1 year
(1996) and consisted of all consecutive AMI patients without an MC
and with an uncomplicated hospital course (no signs of severe heart
failure, infection, bleeding needing blood transfusions, or other seri-
ous disorders affecting study results) and full documentation of CRP
levels and lymphocyte counts. There were 41 control patients who
fulfilled these inclusion criteria.
Study Protocol
We collected the following data: age, gender, coronary risk factors
(smoking, hypertension, body mass index 130 kg/m2, family history
of coronary artery disease, CAD, diabetes mellitus or hyperlipid-
emia), a history of CAD or previous MI, number of coronary arteries
affected by CAD (650% stenosis of major epicardial coronary
artery) and previous coronary artery bypass grafting.
Furthermore, we obtained the following information: infarct
localization (classified as anterior or non-anterior), infarct size (ac-
cording to the peak levels of creatine phosphokinase), transmural
AMI (new Q waves on ECG), infarct-related artery (verified by coro-
nary angiography), percutaneous coronary intervention, medication
between MI and cardiac rupture (aspirin, ß-blockers, thrombolytic
therapy, angiotensin-converting enzyme inhibitors or heparin), se-
rum CRP levels and relative lymphocyte counts.
Laboratory Data
To obtain peak CRP levels and the nadir of relative lymphocyte
counts, all available data from the advent of AMI and the subsequent
first 96 h or until the diagnosis of the MC (if it occurred earlier) were
used (measured at least every 48 h). In the control group, we used all
available data from the first 96 h after the AMI.
CRP levels were measured by a turbidimetric assay (Wako CRP
HR II) with the use of an automatic analysis system (Hitachi 747).
The leukocyte differential analysis was performed with the use of an
automated hematology analyzer (Technicon, Bayer Diagnostics).
Statistical Analysis
Values are expressed as means B SD or percent. Characteristics
were compared between the two groups using the ¯² test, Fisher’s
exact test, the independent-samples t test or the Mann-Whitney U
test, as appropriate. Mean values of CRP levels and lymphocyte
counts were compared between controls and patients with VSD,
PMR, and FWR, respectively, using one-way analysis of variance.
Spearman’s rank correlation was used to test the relationship be-
tween CRP levels and relative lymphocyte counts. Logistic regression
analysis was used to test whether parameters are related to MC and to
calculate odds ratios. After performing univariate analysis, multivar-
iate logistic regression was used to test independency of each parame-
ter found to be significantly related to MC. Bivariate logistic regres-
sion analysis was used to calculate a score, considering both CRP
levels and lymphocyte counts. The area under the receiver-operating
characteristic (ROC) curve, computed by a modification of the Wil-
coxon statistics, as proposed by Hanley and McNeil [15], was used to
determine the discriminatory power of various CRP levels, lympho-
cyte counts and the combined score to predict an MC after AMI. A p
value ^0.05 was considered to show a statistically significant differ-
ence. Analyses were performed using the statistical package SPSS for
Windows 9.0.
Results
Of the 39 mechanical complications, 17 (43%) were
VSD, 12 (31%) FWR, and 10 (26%) PMR occurring 105
B 96 h after the AMI.
Table 1 compares the clinical data of patients with and
without an MC. Patients with MC tended to be older and
showed a male predominance. A history of CAD and MI
as well as a history of hyperlipidemia and smoking were
less common in patients with MC. The higher incidence
of previous coronary bypass grafting in patients without a
rupture was not statistically significant.
The characteristics of AMI are shown in table 2. The
incidence of transmural infarction and non-anterior AMI
was higher in patients with MC than in those without. Sin-
gle-vessel disease was less common in the control group.
There was a higher percentage of patients treated with ß-
blockers and heparin in the group without rupture, where-
as no significant difference was detected in other medica-
tions. Percutaneous coronary interventions were more
CRP and Lymphocytopenia after
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Table 1. Comparison of clinical
characteristics of patients with and without
an MC
MC (n = 36)
% n
Controls (n = 41)
% n
p value
Male gender 58 21 80 33 0.04
Age, years 66B9 61B13 0.05
Coronary risk factors
BMI 130 kg/m2 22 8 17 7 NS
Smoking 56 20 71 29 NS
Hypertension 50 18 56 23 NS
Hyperlipidemia 33 12 63 26 0.01
Family history of CAD 33 12 34 14 NS
Diabetes mellitus 11 4 15 6 NS
Known CAD 8 3 32 13 0.01
Previous MI infarction 8 3 29 12 0.02
Previous CABG 6 2 10 4 NS
BMI = Body mass index; CABG = coronary artery bypass surgery. Numbers and percent-
ages of patients are given except for age.
Table 2. Localization and extent of the MI
and findings of coronary angiography MC (n = 36)
% n
Controls (n = 41)
% n
p value
Inferoposterior location
Anterior location
72
28
26
10
49
51
20
21
0.04
Q-wave MI 89 32 49 20 !0.001
Infarct-related artery NS
LAD 24 8/34 43 12/28
LCX 15 5/34 21 6/28
RCA 62 21/34 36 10/28
Coronary 1-vessel disease 31 11/28 10 3/31 0.04
Thrombolysis 17 6 7 3 NS
Percutaneous coronary intervention 11 4 49 20 !0.001
Medication
ß-Blockers 39 14 93 38 !0.001
ACE inhibitors 22 8 32 13 NS
Heparin 64 23 95 39 !0.001
Statins 17 6 39 16 0.04
Peak values within the first 96 h of AMI
Total CK, U/l 2,002B2,536 1,253B1,164 NS
CRP, mg/l 129B100 42B37 !0.001
Percent lymphocytes of WBC 9.9B7.7 16.3B6.8 !0.001
LAD = Left anterior descending coronary artery; LCX = left circumflex coronary artery;
RCA = right coronary artery; CK = creatine phosphokinase. Numbers and percentages of
patients are given except for peak values within the first 96 h after AMI.
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Table 3. Comparison of CRP levels and
lymphocyte counts in patients with various
MC and in control patients
Controls
(n = 41)
VSD
(n = 17)
PMR
(n = 10)
FWR
(n = 12)
ANOVA
p
CRPpeak, mg/l 49B50 96B63 173B118 150B125 !0.001
LYCmin, % of WBC 16.2B6.9 8.5B3.4 6.9B4.7 9.7B8.9 !0.001
Table 4. Summary of the odds ratios for
MC in univariate and multivariate analyses ODDS
ratio
Confidence
interval
ODDS
ratio
Confidence
interval
Univariate predictors (n = 77)
CRPpeak, mg/l 1.017c 1.008–1.027 1.022c 1.01–1.03
LYCmin, % of WBC 0.810d 0.729–0.901 0.873b 0.80–0.95
ß-Blockade 0.05d 0.01–0.19
Heparin 0.09b 0.02–0.44
Q-wave infarction 8.40c 2.51–28.06
PTCA 0.13c 0.04–0.44
Age, per year 1.043a 1.000–1.089
Hyperlipidemia 0.30b 0.11–0.74
Sex, female 2.95a 1.07–8.15
1-vessel disease 4.89a 1.21–19.75
Previous MI 0.22a 0.06–0.86
Known CAD 0.20a 0.05–0.76
Combined predictor
Score, CRPpeak – 10 ! Lycmin 1.015d 1.008–1.023 1.019d 1.010–1.029
Multivariate predictor
CRPpeak, mg/l 1.015b 1.005–1.026
Lycmin, % WBC 0.838b 0.733–0.958
ß-Blockade 0.02c 0.00–0.15
a p ! 0.01, b p ! 0.005, c p ! 0.001, d p ! 0.0001.
common in control patients. There was no significant dif-
ference in peak CK levels. In patients undergoing coro-
nary angiography, no significant difference could be de-
tected in the infarct-related artery.
As shown in table 2, there were significant differences
in peak CRP levels and relative lymphocyte counts,
respectively, comparing patients with and without MC. In
table 3, CRP levels and lymphocyte counts were com-
pared between control patients and the three different
MC. FWR resulted in the highest CRP levels, followed by
PMR and VSD. Relative lymphocyte counts were lowest
in patients with PMR. However, all the differences be-
tween the different complications were not statistically
significant.
Odds ratios of CRP levels and relative lymphocyte
counts for the detection of MC are shown in table 4. Var-
ious variables were related to the risk of MC. Of these,
elevated CRP levels and relative lymphopenia obtained
prior to the MC were among the most significant predic-
tors.
Figure 1 shows the ROC curves of the CRP levels and
the lymphocyte counts, indicating the predictive value of
the two parameters. A CRP level of 60 mg/l, for example,
has a sensitivity of 79% and a specificity of 78%; a relative
lymphocyte count of 11% has a sensitivity of 75% with a
specificity of 75%. The coefficients of bivariate logistic
regression led to a score using the following formula:
CRP (mg/l) – 10 ! Lyc (%)
where CRP is the CRP level (in mg/dl) and Lyc equals the
fraction of lymphocytes of the WBC count expressed in
percent. Low scores indicate a low risk of MC.
Figure 2 depicts the ROC curve of this score to detect
an MC. The area under the curve of 0.90 indicates the
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high predictive value of this score. As a cutoff value, 50
could be identified, which seemed to be ideal with high
sensitivity (i.e. 90%) and acceptable specificity (i.e.
83%).
Despite a significant correlation between CRP levels
and relative lymphocyte counts (r = –0.40, p ! 0.001),
multivariate logistic regression analysis revealed CRP lev-
els and lymphocyte counts as independent predictors of
prognosis. The only other independent predictor of MC
was the use of ß-blockade.
Discussion
One key to successful treatment of an MC after AMI is
the identification of those patients at greatest risk, en-
abling early diagnosis and adequate treatment [12, 16–
19]. Our study shows that early identification of an MC
may be improved using a new simple score with peak
CRP levels and the nadir of the percentage of lympho-
cytes which precede the MC. This score correctly identi-
fied the majority of patients suffering MC with an accept-
able specificity.
Clinical and Pathologic Risk Factors for Cardiac
Rupture
Our results confirmed previous findings that patients
with an MC are older and more likely to have a transmu-
ral infarction, less severe degrees of CAD (single-vessel
disease or no CAD) and no previous MI [2–4, 6, 7, 11].
Furthermore, in agreement with earlier studies, we found
that rupture occurs less frequently in patients treated with
ß-blockers immediately after the AMI [20]. This may be
of clinical importance since the consequent use of early
ß-blockade seems to be the most effectual measure of pre-
venting MC after AMI. This may be one of the reasons for
the reduction in clinical events by ß-blockade after AMI.
Fig. 1. ROC curves for prediction of MC after MI using relative lym-
phocyte counts (a) and CRP levels (b). a, b Minimal lymphocyte and
peak CRP values within the first 96 h of AMI. CRPpeak = Peak level
of CRP (mg/l); Lycmin = minimal lymphocyte count (% of WBCs);
AUC = area under the curve. The numbers beneath the curves denote
the corresponding numerical values.
Fig. 2. ROC curves for the prediction of MC after MI using the score
CRP (mg/l) – 10 ! Lyc (%). CRPpeak = Peak CRP level; Lycmin =
minimal relative lymphocyte count; AUC = area under the curve.
The numbers beneath the curves denote the corresponding numer-
ical values. Thus, a score of –50 has a sensitivity of 90% and a speci-
ficity of 83% for the prediction of MC.
1
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There is, however, controversy regarding the site of
infarction leading to rupture [1, 2, 21]. The present study
showed a significant prevalence of the inferoposterior
location in patients with rupture, which may be in line
with a recent publication [22]. This was especially due to
an increased incidence of inferior or posterior infarctions
leading to PMR or FWR compared to anterior MI.
While all patients of the control group had been admit-
ted directly to our medical department, 89% of the
patients of the group with MC were referrals from other
hospitals where a percutaneous coronary intervention
after the AMI was not available. Therefore, the higher fre-
quency of percutaneous coronary interventions in pa-
tients of the control group should not be overestimated.
Recent data seem to indicate that primary angioplasty
may reduce the risk of myocardial rupture compared to
thrombolysis for AMI (a 100% decrease in VSD) [23].
No significant difference among the two groups could
be established regarding the incidence of thrombolysis,
previous coronary artery bypass grafting or the infarct-
related artery. This is probably due to the small number of
patients since it is known from the GUSTO-I trial that the
occurrence of VSD after AMI is less frequent in the
thrombolytic area than it was before [24].
C-Reactive Protein
CRP is an acute-phase protein and is produced in hepa-
tocytes by the stimulation of various cytokines, including
interleukin-6, tumor necrosis factor and interleukin-1,
which are released from monocytes and macrophages acti-
vated by inflammation, as observed in AMI. It is presumed
that a massive local cardiac inflammation causes severe
tissue vulnerability due to proteolytic enzymes from poly-
morphonuclear leukocytes, and, thus, contributes to rup-
ture [2, 11, 16]. Therefore, a strong increase in serum CRP
level, reflecting a high degree of inflammation, was sug-
gested to be used for the identification of postinfarct
patients at high risk for rupture [8, 11]. The present study
strongly supports this conclusion, suggesting an increase in
CRP level after AMI as a marker for increased risk not only
of free wall rupture but also of PMR and VSD.
It could be contradicted that the increase in the CRP
level might not only be the result of the inflammation
induced by the infarcted tissue, but also a consequence of
an already progressing subacute rupture, causing inflam-
mation through intramyocardial hemorrhage. Although
this contention cannot be ruled out completely, the time
course of CRP levels favors the assumption of an in-
fluence of the inflammation process on the occurrence of
MC. Thus, the peak CRP level was earlier than the MC in
most patients (data not shown). If peak CRP levels had
been influenced by a subacute rupturing process, they
would have had to persist or even increase until the clini-
cal diagnosis of the rupture. Additionally, it is important
to note that CRP levels are related to MC after AMI irre-
spectively of the underlying mechanism and, therefore,
useful in the risk assessment of patients after AMI.
Relative Lymphocytopenia
It is known that the relative lymphocytopenia after
AMI is caused by an increase in cortisol release which is
induced by myocardial necrosis and depends on the size
of necrotic tissue [25]. Therefore, a low relative lympho-
cyte count, based upon a high cortisol level, would refer to
a large amount of necrotic tissue and possibly a correla-
tion between the size of infarcted tissue and its risk to rup-
ture. Thus, a relatively low lymphocyte count could be
used as a poor prognostic marker in patients after AMI.
The result of our study confirmed the high risk of MC in
patients with a low relative lymphocyte level.
However, the correlation between the low relative lym-
phocyte level and the risk of rupture could not be
explained solely by the size of the infarcted region, as our
results, as well as those of others, showed no significant
correlation between the size of infarct (assessed by peak
creatine kinase levels) and the risk of its rupture. Further
elements which induce a cortisol release seem to influence
the complication rate of MC after an AMI. On the other
hand, peak creatine kinase levels are not optimal to esti-
mate infarct size and may be inferior to serum-time activ-
ity curves of creatine kinase or serial myoglobin measure-
ments [26, 27].
Risk Score and ROC Curves
The multivariate analysis clearly demonstrated that
both maximum CRP levels and minimal relative lympho-
cyte counts were independent predictors of MC. Impor-
tantly, despite the significant negative correlation be-
tween them, both variables independently and additional-
ly contributed to the identification of patients at risk for
MC. Accordingly, the combination of both resulted in an
even more powerful marker for MC after AMI than either
of the two variables alone.
Study Limitations
The major limitation of this study is its retrospective
design. Therefore, CRP levels and lymphocyte counts
were not assessed daily in every patient, and consequently
information on their exact time course or nadir are not
available. However, measurement of CRP levels at our
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hospital have been part of the routine for 110 years due to a
special interest of our hematologist. The control population
has only been recruited during 1 year and is relatively small.
However, these are consecutive patients with little varia-
tion and, therefore, we do not think that this would have
significantly affected our data. In addition, 1996 is still rep-
resentative as statins were not routinely administered in the
acute infarct setting at that time. However, statins were
significantly less often given in the group with MC than in
the control population. However, we are doubtful – but
cannot exclude – that statins would have influenced the
results as the reduction in CRP levels by statin therapy is
only very small, e.g. 0.2 mg/dl in the PRINCE trial [28].
Patients with severe heart failure or a concomitant
infection were excluded from the control group. This will
affect the diagnostic accuracy of this score which is only as
good as we describe it for patients with an otherwise
uncomplicated hospital course.
Not all of our patients with an AMI and not all patients
in the control group have had an echocardiographic exam-
ination, therefore, we cannot exclude that some patients
had an asymptomatic MC, especially, an FWR.
Conclusions
Combined use of peak CRP level and the nadir of rela-
tive lymphocyte count (using a combined score) enables
accurate prediction of an MC after an AMI and should be
used routinely. Prospective data are needed to clearly
define the diagnostic accuracy of the score found in our
study population.
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